The Mérieux Participations 2 fund (“MP2”) has completed the sale of its minority stake in Laboratoires INELDEA. This exit results in a multiple of nearly 2.9x and an IRR of approximately 40%.
Present CEO, Niklas Ahlborg, will remain at the company as a Senior Advisor.
This investment builds on a long-standing collaboration in biocontrol and pollination which began in 1992.
The business purpose of the new joint venture is to promote Ceva’s image and business strategy to potential Japanese partners.